We found the decrease of CD160, Siglec-7, NKp46 and NKp30 expression and increase of CD49a, Siglec-10, PD-1 and ILT2 expression on peripheral NK cells in HCC patients with liver cirrhosis, compared with HVs (Figure 5). This evidence concerns the gene CD160 and hepatocellular carcinoma.